These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 382787)

  • 1. Pathogenesis of myasthenia gravis as a disorder of acetylcholine receptors.
    Drachman DB; Pestronk A; Stanley EF
    Adv Cytopharmacol; 1979; 3():237-44. PubMed ID: 382787
    [No Abstract]   [Full Text] [Related]  

  • 2. Myasthenia gravis (first of two parts).
    Drachman DB
    N Engl J Med; 1978 Jan; 298(3):136-42. PubMed ID: 201840
    [No Abstract]   [Full Text] [Related]  

  • 3. Myasthenia gravis. Study of humoral immune mechanisms by passive transfer to mice.
    Toyka KV; Drachman DB; Griffin DE; Pestronk A; Winkelstein JA; Fishbeck KH; Kao I
    N Engl J Med; 1977 Jan; 296(3):125-31. PubMed ID: 831074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How the autoimmune response to acetylcholine receptor impairs neuromuscular transmission in myasthenia gravis and its animal model.
    Lindstrom J
    Fed Proc; 1978 Dec; 37(14):2828-30. PubMed ID: 214352
    [No Abstract]   [Full Text] [Related]  

  • 5. Inhibition of alpha-bungarotoxin binding to acetylcholine receptors by antisera from animals with experimental autoimmune myasthenia gravis.
    Claudio T; Raftery MA
    J Supramol Struct; 1980; 14(3):267-79. PubMed ID: 6971372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Immunologic aspects of disorders of neuromuscular transmission. 2. Experimental autoimmune myasthenia gravis and the Lambert-Eaton myasthenic syndrome].
    Andreis I; Lovnićki TJ; Beara N; Taradi M
    Lijec Vjesn; 1994; 116(5-6):158-61. PubMed ID: 7968205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of acetylcholine receptor antibodies in myasthenia gravis.
    Appel SH; Elias SB; Chauvin P
    Fed Proc; 1979 Sep; 38(10):2381-5. PubMed ID: 478014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The biology of myasthenia gravis.
    Drachman DB
    Annu Rev Neurosci; 1981; 4():195-225. PubMed ID: 7013636
    [No Abstract]   [Full Text] [Related]  

  • 9. [alpha-Bungarotoxin and acetylcholine receptor (author's transl)].
    Takamori M; Ishii N; Tsujihata M; Mori M; Kasai M
    No To Shinkei; 1977 Jun; 29(6):597-607. PubMed ID: 334200
    [No Abstract]   [Full Text] [Related]  

  • 10. Myasthenia gravis: a personal view of pathogenesis and mechanism, part 1.
    Simpson JA
    Muscle Nerve; 1978; 1(1):45-56. PubMed ID: 377070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunopathology of myasthenia gravis.
    Drachman DB
    Fed Proc; 1979 Nov; 38(12):2613-5. PubMed ID: 227751
    [No Abstract]   [Full Text] [Related]  

  • 12. The immunopathological basis of acetylcholine receptor deficiency in myasthenia gravis.
    Engel AG
    Prog Brain Res; 1979; 49():423-34. PubMed ID: 515440
    [No Abstract]   [Full Text] [Related]  

  • 13. [Pathogenesis and pathophysiology of myasthenia gravis--electrophysiological, ultrastructural and immunological aspects of neuromuscular junctions (author's transl)].
    Takamori M; Tsujihata M; Ide Y; Eguchi K; Mine M
    No To Shinkei; 1980 Sep; 32(9):891-908. PubMed ID: 6254548
    [No Abstract]   [Full Text] [Related]  

  • 14. Heterogeneity of acetylcholine receptors in denervated muscle: interactions of receptors with immunoglobulin from patients with myasthenia gravis.
    Mittag TW; Tormay A; Massa T
    Mol Pharmacol; 1978 Jan; 14(1):60-8. PubMed ID: 625290
    [No Abstract]   [Full Text] [Related]  

  • 15. [Myasthenia gravis in newborn infants--pathological mechanism, clinical symptomatology and therapeutic procedures].
    Krauze M; Musialik E; Swietliński J; Litwa K; Latko E; Górny J; Sobczyk J
    Wiad Lek; 1992 Aug; 45(15-16):610-4. PubMed ID: 1488831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunological studies of acetylcholine receptors.
    Lindstrom J
    J Supramol Struct; 1976; 4(3):389-403. PubMed ID: 817087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Postsynapic membrane of Torpedo electroplax: acetylcholine receptor localization and its use as a tool in the study of cellular immuninty in myasthenia gravis.
    Conti-Tronconi B; Morgutti M; Gotti C; Clementi F
    Adv Cytopharmacol; 1979; 3():255-67. PubMed ID: 382788
    [No Abstract]   [Full Text] [Related]  

  • 18. Anti-MuSK patient antibodies disrupt the mouse neuromuscular junction.
    Cole RN; Reddel SW; Gervásio OL; Phillips WD
    Ann Neurol; 2008 Jun; 63(6):782-9. PubMed ID: 18384168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytophilic antibodies in experimental autoimmune myasthenia gravis.
    Martinez RD; Tarrab-Hazdai R; Aharonov A; Fuchs S
    J Immunol; 1977 Jan; 118(1):17-20. PubMed ID: 830746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Experimental autoimmune myasthenia gravis: can pretreatment with 125I-labeled receptor prevent functional damage at the neuromuscular junction?
    Sterz RK; Biro G; Rajki K; Filipp G; Peper K
    J Immunol; 1985 Feb; 134(2):841-6. PubMed ID: 2578165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.